Cargando…

Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer

BACKGROUND: Gastric cancer is one of the major causes of cancer-related mortality worldwide. Most of patients presenting with inoperable gastric cancers rely on systemic chemotherapy for prolongation of survival. Doxorubicin (DOX) is one of the important agents against gastric cancer. Acquired DOX-r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jiahui, Liu, Deying, Niu, Huilin, Zhu, Guifang, Xu, Yangwei, Ye, Danli, Li, Jian, Zhang, Qingling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270306/ https://www.ncbi.nlm.nih.gov/pubmed/28126034 http://dx.doi.org/10.1186/s13046-016-0487-8

Ejemplares similares

Correction: Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/ Akt signaling pathway in gastric cancer
por: Xu, Jiahui, et al.
Publicado: (2023)

WTX inhibits gastric cancer migration through the reversal of epithelial-mesenchymal transition
por: Ye, Danli, et al.
Publicado: (2018)

Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway
por: Li, Jian, et al.
Publicado: (2020)

Correction to: Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway
por: Li, Jian, et al.
Publicado: (2021)

Resveratrol-Mediated Reversal of Doxorubicin-Induced Osteoclast Differentiation
por: Poudel, Sunil, et al.
Publicado: (2022)

Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway
por: Wang, Sheng-Chun, et al.
Publicado: (2015)

Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023)

A new dimension in drug discovery: reversing epithelial–mesenchymal transition (EMT)
por: Yun-Ju Huang, Ruby, et al.
Publicado: (2016)

Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer
por: Wang, Ye, et al.
Publicado: (2020)

Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors
por: Guo, Kaibo, et al.
Publicado: (2021)

The DeltaN p63 Promotes EMT and Metastasis in Bladder Cancer by the PTEN/AKT Signalling Pathway
por: Tian, Yong-Hua, et al.
Publicado: (2022)

Epithelial–Mesenchymal Transition (EMT) 2021
por: Manfioletti, Guidalberto, et al.
Publicado: (2022)

Antagonism of miR-21 Reverses Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype through AKT/ERK1/2 Inactivation by Targeting PTEN
por: Han, Mingli, et al.
Publicado: (2012)

Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer [Retraction]
Publicado: (2023)

Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway
por: Li, Ling-Li, et al.
Publicado: (2020)

The Role of PTEN in Epithelial–Mesenchymal Transition
por: Fedorova, Olga, et al.
Publicado: (2022)

Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
por: Yoshida, T, et al.
Publicado: (2014)

Doxorubicin-Induced Cancer Cell Senescence Shows a Time Delay Effect and Is Inhibited by Epithelial-Mesenchymal Transition (EMT)
por: Hu, Xuerui, et al.
Publicado: (2019)

SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration
por: Eguchi, Takanori, et al.
Publicado: (2022)

JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling
por: Lei, Xiong, et al.
Publicado: (2016)

Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling
por: Dai, Hanhan, et al.
Publicado: (2020)

Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells
por: HUANG, FANG, et al.
Publicado: (2014)

Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial- mesenchymal transition via the AKT/GSK-3β/Snail signaling pathway
por: Yuan, Li, et al.
Publicado: (2019)

Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial-mesenchymal transition via the AKT/GSK-3β/Snail signaling pathway
por: Yuan, Li, et al.
Publicado: (2022)

MicroRNA-10 Family Promotes the Epithelial-to-Mesenchymal Transition in Renal Fibrosis by the PTEN/Akt Pathway
por: Wang, Chaokun, et al.
Publicado: (2022)

Resveratrol protects the integrity of alveolar epithelial barrier via SIRT1/PTEN/p‐Akt pathway in methamphetamine‐induced chronic lung injury
por: Wang, Xin, et al.
Publicado: (2020)

Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway
por: Li, Jie, et al.
Publicado: (2018)

Role of Metabolic Reprogramming in Epithelial–Mesenchymal Transition (EMT)
por: Kang, Hyunkoo, et al.
Publicado: (2019)

The Epithelial-to-Mesenchymal Transition (EMT), a Particular Case
por: Cebrià-Costa, Joan Pau, et al.
Publicado: (2014)

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

Involvement of Epithelial-Mesenchymal Transition (EMT) in Autoimmune Diseases
por: Sarrand, Julie, et al.
Publicado: (2023)

A novel anti-cancer effect of resveratrol: reversal of epithelial-mesenchymal transition in prostate cancer cells
por: LI, JIANPING, et al.
Publicado: (2014)

WFDC2 contributes to epithelial–mesenchymal transition (EMT) by activating AKT signaling pathway and regulating MMP-2 expression
por: Chen, Yao, et al.
Publicado: (2019)

Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
por: Zhao, Yuan, et al.
Publicado: (2016)

Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial‐mesenchymal transition and modulating SIRT1/β‐catenin signaling pathway in breast cancer
por: Jin, Xiaoxia, et al.
Publicado: (2019)

JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells
por: Tang, Bo, et al.
Publicado: (2015)

MicroRNA-216a promotes the metastasis and epithelial–mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway
por: Liu, Haizhi, et al.
Publicado: (2017)

Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol
por: Buhrmann, Constanze, et al.
Publicado: (2019)

Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases
por: Zvaifler, Nathan J
Publicado: (2006)

Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression
por: Grant, Campbell M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vnamsqkphtb33og1ivehsr5eah